• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米医学中的协同作用:不是什么,可能是什么。

Synergy in Nanomedicine: What It Is Not, and What It Might Be.

作者信息

Staffa Steven J, Kohane Daniel S, Zurakowski David

机构信息

Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston Massachusetts 02115, United States.

出版信息

Nano Lett. 2021 Jul 14;21(13):5457-5460. doi: 10.1021/acs.nanolett.1c01894. Epub 2021 Jun 29.

DOI:10.1021/acs.nanolett.1c01894
PMID:34185537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8950954/
Abstract

Interactions between nanoformulations delivering two or more drugs-or a drug and some other therapeutic modality-are often described as synergistic. In fact, synergy is a specific term of art, with important therapeutic implications. The term is often misused in the nanoscience literature. Here we discuss what synergy is and an approach to demonstrating it rigorously.

摘要

递送两种或更多种药物——或一种药物与某种其他治疗方式——的纳米制剂之间的相互作用通常被描述为具有协同作用。事实上,协同作用是一个具有重要治疗意义的特定专业术语。该术语在纳米科学文献中经常被误用。在此,我们将讨论协同作用是什么以及一种严格证明它的方法。

相似文献

1
Synergy in Nanomedicine: What It Is Not, and What It Might Be.纳米医学中的协同作用:不是什么,可能是什么。
Nano Lett. 2021 Jul 14;21(13):5457-5460. doi: 10.1021/acs.nanolett.1c01894. Epub 2021 Jun 29.
2
Method to Assess Interactivity of Drugs with Nonparallel Concentration Effect Relationships.评估药物与非平行浓度效应关系的相互作用的方法。
Curr Cancer Drug Targets. 2017;17(8):735-755. doi: 10.2174/1568009617666170330154054.
3
Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.利用亚细胞靶向提高癌症治疗效果的纳米医学精确设计策略。
Signal Transduct Target Ther. 2020 Nov 6;5(1):262. doi: 10.1038/s41392-020-00342-0.
4
Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility.协同作用是规律吗?关于产生催眠和不动效果的麻醉相互作用的综述。
Anesth Analg. 2008 Aug;107(2):494-506. doi: 10.1213/ane.0b013e31817b859e.
5
Decimal assay for additivity of drugs permits delineation of synergy and antagonism.药物相加性的十进制分析可明确协同作用和拮抗作用。
Antimicrob Agents Chemother. 1993 Feb;37(2):260-4. doi: 10.1128/AAC.37.2.260.
6
Heat/pH-boosted release of 5-fluorouracil and albumin-bound paclitaxel from Cu-doped layered double hydroxide nanomedicine for synergistical chemo-photo-therapy of breast cancer.载铜层状双氢氧化物纳米药物中 5-氟尿嘧啶和白蛋白结合紫杉醇的热/酸碱响应释放用于协同的乳腺癌化学-光热治疗。
J Control Release. 2021 Jul 10;335:49-58. doi: 10.1016/j.jconrel.2021.05.011. Epub 2021 May 12.
7
An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.化学协同作用的术语和方法导论——跨学科视角
Front Pharmacol. 2017 Apr 20;8:158. doi: 10.3389/fphar.2017.00158. eCollection 2017.
8
In silico drug combination discovery for personalized cancer therapy.用于个性化癌症治疗的计算机辅助药物组合发现
BMC Syst Biol. 2018 Mar 19;12(Suppl 2):16. doi: 10.1186/s12918-018-0546-1.
9
Combinations of PARP, hedgehog and HDAC inhibitors with standard drugs.聚腺苷二磷酸核糖聚合酶、 hedgehog 和组蛋白去乙酰化酶抑制剂与标准药物的联合应用。
Curr Opin Pharmacol. 2010 Aug;10(4):397-404. doi: 10.1016/j.coph.2010.04.014. Epub 2010 May 22.
10
Mixed Beam Murine Harderian Gland Tumorigenesis: Predicted Dose-Effect Relationships if neither Synergism nor Antagonism Occurs.混合束诱导小鼠哈德氏腺肿瘤发生:若既无协同作用也无拮抗作用时的预测剂量效应关系。
Radiat Res. 2016 Dec;186(6):577-591. doi: 10.1667/RR14411.1. Epub 2016 Nov 22.

引用本文的文献

1
The Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib.负载大麻二酚、塞来昔布和2,5-二甲基塞来昔布的新型脂质体制剂的抗胶质母细胞瘤作用
Pharmaceutics. 2025 Aug 8;17(8):1031. doi: 10.3390/pharmaceutics17081031.
2
GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism.GCK抑制通过一种不依赖CRBN的机制促进IKZF1降解,从而增强艾伯多米德的抗骨髓瘤作用。
Blood Neoplasia. 2025 Jun 19;2(3):100130. doi: 10.1016/j.bneo.2025.100130. eCollection 2025 Aug.
3
Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine.利用纳米技术进行药物输送:提高中药自噬调节化合物的抗癌效果。
Int J Nanomedicine. 2024 Mar 12;19:2507-2528. doi: 10.2147/IJN.S455407. eCollection 2024.
4
Materials for Controlled Release of Local Anesthetics.局部麻醉药控释材料。
ChemMedChem. 2023 Jun 1;18(11):e202300009. doi: 10.1002/cmdc.202300009. Epub 2023 Apr 18.
5
Enzyme-Enhanced Codelivery of Doxorubicin and Bcl-2 Inhibitor by Electrospun Nanofibers for Synergistic Inhibition of Prostate Cancer Recurrence.通过静电纺丝纳米纤维实现阿霉素和Bcl-2抑制剂的酶增强共递送以协同抑制前列腺癌复发
Pharmaceuticals (Basel). 2022 Oct 10;15(10):1244. doi: 10.3390/ph15101244.
6
Simultaneous Exposure of Different Nanoparticles Influences Cell Uptake.不同纳米颗粒的同时暴露会影响细胞摄取。
Pharmaceutics. 2022 Jan 6;14(1):136. doi: 10.3390/pharmaceutics14010136.

本文引用的文献

1
Recent advances in functional mesoporous silica-based nanoplatforms for combinational photo-chemotherapy of cancer.用于癌症联合光化疗的功能性介孔二氧化硅基纳米平台的最新进展。
Biomaterials. 2020 Feb;232:119738. doi: 10.1016/j.biomaterials.2019.119738. Epub 2019 Dec 27.
2
Additive Dose Response Models: Defining Synergy.加性剂量反应模型:协同作用的定义
Front Pharmacol. 2019 Nov 26;10:1384. doi: 10.3389/fphar.2019.01384. eCollection 2019.
3
Statistical determination of synergy based on Bliss definition of drugs independence.基于 Bliss 定义的药物独立性,通过统计学方法确定协同作用。
PLoS One. 2019 Nov 25;14(11):e0224137. doi: 10.1371/journal.pone.0224137. eCollection 2019.
4
An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.化学协同作用的术语和方法导论——跨学科视角
Front Pharmacol. 2017 Apr 20;8:158. doi: 10.3389/fphar.2017.00158. eCollection 2017.
5
Analysis of drug combinations: current methodological landscape.药物联合分析:当前方法学全景。
Pharmacol Res Perspect. 2015 Jun;3(3):e00149. doi: 10.1002/prp2.149. Epub 2015 May 20.
6
Nanoparticle-Based Combination Therapy for Cancer Treatment.基于纳米颗粒的癌症联合治疗
Curr Pharm Des. 2015;21(22):3158-66. doi: 10.2174/1381612821666150531165059.
7
Understanding synergy.理解协同作用。
Am J Physiol Endocrinol Metab. 2013 Feb 1;304(3):E237-53. doi: 10.1152/ajpendo.00308.2012. Epub 2012 Dec 4.
8
Quantitative methods for assessing drug synergism.评估药物协同作用的定量方法。
Genes Cancer. 2011 Nov;2(11):1003-8. doi: 10.1177/1947601912440575.
9
Revisiting the isobole and related quantitative methods for assessing drug synergism.重新探讨等摩尔线和相关的定量方法评估药物协同作用。
J Pharmacol Exp Ther. 2012 Jul;342(1):2-8. doi: 10.1124/jpet.112.193474. Epub 2012 Apr 17.
10
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer.基于纳米颗粒的联合治疗策略克服癌症的耐药性。
Biochem Pharmacol. 2012 Apr 15;83(8):1104-11. doi: 10.1016/j.bcp.2012.01.008. Epub 2012 Jan 18.